Vaccines for COVID-19: Canada’s vaccine supply
On this page
Making vaccines available to everyone
COVID-19 vaccines are available to every eligible person in Canada.
Vaccine supply continues to be managed strategically to best support both Canada’s evolving domestic needs and global vaccination efforts.
Canada’s vaccine supply includes a central inventory allocated to the provinces and territories and held at their request. It also includes supply to provide provinces and territories with continued access to vaccines for newly eligible populations and for additional doses that may be needed over time.
The vaccine distribution table (updated every Thursday) below describes the quantities of COVID-19 vaccines that have been delivered to provinces and territories.
As of September 9, 2021 there are 10,428,326 COVID-19 vaccine doses in the central vaccine inventory.
AstraZeneca COVID-19 vaccine include vaccine doses coming from the Serum Institute of India, United States and the COVAX initiative.
|Total distributed in Canada||42,888,420||18,046,098||3,005,780||63,940,298|
|Newfoundland and Labrador||558,870||276,180||41,100||876,150|
|Prince Edward Island||197,445||75,980||9,900||283,325|
|Federal allocationFootnote 1||3,396||204,938||460||208,794|
Pfizer vaccine forecasted allocation
Forecasted allocation of Pfizer-BioNTech COVID-19 vaccine to provinces and territories
Current Pfizer-BioNTech allocations are based on a 6 dose per vial product monograph.
|Distribution location||September 4 to September 10|
|Total forecasted allocations||0|
|Newfoundland and Labrador||0|
|Prince Edward Island||0|
Thank you for your feedback
- Date modified: